COVID-19 as a Trigger for ME/CFS: Severity Biomarkers and Underlying Mechanisms

The recording from COVID-19 as a Trigger for ME/CFS: Severity Biomarkers and Underlying Mechanisms is now available to view online. In this webinar, Prof. Dr. Carmen Scheibenbogen (Acting Director of Charité’s Institute of Medical Immunology on Campus Virchow-Klinikum and Solve M.E. Ramsay Research Grant awardee) discussed the findings of a recent study by a group of researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC), and how the new findings may help researchers to develop specific treatments for post-Covid ME/CFS and ME/CFS.